The global Histopathology Services Market was valued at USD 22.8 Billion in 2022 and it is anticipated to grow up to USD 38.4 Billion by 2032, at a CAGR of 5.4% during the forecast period.
Histopathology services are used in the examination of biological tissues for the diagnosis of diseases. The procedure includes microscopic examination of tissues. With the help of imaging techniques biopsy tissues can now be obtained from certain inaccessible sites such as pancreas and the peritoneum.
Market Trends and Drivers
Factors such as rising demand for biologics and increasing prevalence of chronic diseases are driving the histopathology services market. However, limitations associated with histopathology and immunohistochemistry are expected to restrict the market growth to a certain extent during the forecast period. Further, increasing government support to advance the smart technologies in preliminary diagnosis has led to robust development of histopathology services. Additionally, technology has played crucial in minimizing the complication of the manual process and advanced the existing histopathology technologies. Other factors like increasing public investments in advancing the histopathology services have fuelled the growth of the market. On the other hand, limitations associated with histopathology and immunohistochemistry is expected to restrain the overall market growth to a certain extent during the forecast period.
Market Restraints and Challenges
The disadvantages of histology and histological staining include: Preparation of the slides using the paraffin technique can be time-consuming; frozen slides are faster to prepare, but this can affect the resolution, especially when using light microscopy. However, limitations associated with histopathology and immunohistochemistry are expected to restrict the market growth to a certain extent during the forecast period. Subspecialisation in the diagnostic surgical pathology service and cytology; frozen sections; the autopsy; multidisciplinary team meetings; ancillary techniques; the pathology report and some other administrative duties.
The report analyses the global Histopathology Services Market based on Type, End-user, and region
Global Histopathology Services Market by Type
Based on type, is segmented into surgical specimen, breast biopsy, lung biopsy, renal biopsy, gastrointestinal biopsy, pancreatic biopsy, skin tissue biopsy, testicular biopsy, and others. the surgical specimen segment dominated the market in 2022, and this trend is expected to continue during the forecast period, owing to increase in number of various types of surgical procedures, rise in demand for diagnosis of chronic diseases, and surge in adoption of diagnostic systems. However, the liver biopsy segment is expected to witness considerable growth during the forecast period, owing to increase in number of liver cancer cases and growth in number of key players for development of histopathology services systems in the healthcare industry. the surgical specimen segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to increase in number of various types of surgical procedures, rise in demand for diagnosis of chronic diseases, and surge in adoption of diagnostic systems. However, the liver biopsy segment is expected to witness considerable growth during the forecast period, owing to increase in number of liver cancer cases and growth in number of key players for development of histopathology services systems in the healthcare industry.
Global Histopathology Services Market by End-user
Based on end user, the histopathology services market has been segmented into diagnostic laboratories and reference laboratories, research institutes, and others; the diagnostic laboratories and reference laboratories segment held the largest market share in 2021, and the same segment is predicted to register the highest CAGR during 2022–2032.
Geographical Analysis of Global Histopathology Services Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. In 2022, North America dominated the histopathology services market. The US is the major contributor to the market growth in the region; moreover, rising public health awareness, increasing strategic activities by governments, and presence of leading market players support the regional market growth. The growth of the market can be because of prevalence of various diseases, government support for biotechnology and increasing efforts in R&D activities as well as other activities undertaken by the market players operating in the market. In addition, technological advancements in the diagnosis industry is likely to stimulate the growth of histopathology services market in North America. On the other hand, large pool of population suffering with chronic diseases, rapidly developing healthcare infrastructure, and intellectual capabilities of scientists and researchers in the Asia Pacific is expected to account for the fastest growth of the region during the coming years.
Major Players in the Global Histopathology Services Market
The key players in the market are Sonic Healthcare Limited; Laboratory Corporation of America Holdings; Acculabs Diagnostics UK Ltd; TPL Path Labs; UNILABS; Cureline Global Translational CRO; Targos; Cellular Pathology Services; Experimental Pathology Laboratories Inc (EPL); and CHARLES RIVER LABORATORIES, INC.. among others.
COVID-19 Impact:
At present, COVID-19 has made a major impact on the healthcare industry. Since the outbreak reached the U.S. in January 2020, hospitals, pharmacies, and other facilities have had to address challenges at a magnitude that had never been seen before. Moreover, according to a recent survey by Medscape in April 2020, substantial disruption have been witnessed in routine cancer care that includes tests for screening and diagnosis in suspected cases to their treatment as a result of the COVID-19 pandemic. The rapid increase in the number of infected patients in the US and Canada is likely to hamper the growth of histopathology services market and result in slowing down the market growth in the near future. Currently, many countries are now undergoing lockdown relaxations, and most hospitals have resumed elective surgeries. As a result, the number of diagnostic tests conducted is now increasing. Owing to the factors mentioned above, the overall growth rate of the anatomic pathology market is less when compared to the previous year.
Recent Developments:
- In May 2021, Discovery Life Sciences (Discovery), acquired Targos Molecular Pathology GmbH, Germany (Targos), to significantly expand its global tissue biomarker services. The addition of Targos immediately expands Discovery's capabilities on a global scale to support our customers' tissue biomarker programs for every stage of research.
- In Mar 2020, Charles River Laboratories International, Inc. announced that it has entered into a partnership with Deciphex, a leader in preclinical digital pathology software-as-a-service. Through this agreement, in addition to Charles River being the exclusive contract research organization distributing the Patholytix Preclinical solution to clients, the organizations will work together to co-develop deep learning-enabled tools to support accelerated pathology analytics.
- In November 2020, Cerner rolled out new communication capabilities across its online patient portal to save time spent by the staff on administrative tasks and boost consumer engagement.
- In April 2021, Telemedicine Clinic (A Unilabs Company), in partnership with Alliance Medical and Doncaster Clinical Commissioning Group (CCG), has started providing reporting services for low dose CT scans as part of the UK NHS’s Targeted National Lung Health Check program.
Q1. How big is the Knowledge Process Outsourcing Market?Ans. The global Histopathology Services Market was valued at USD 22.8 Billion in 2022 and it is anticipated to grow up to USD 38.4 Billion by 2032, at a CAGR of 5.4% during the forecast period.Q2. What is the Histopathology Services Market growth rate?Ans. The growth rate of the Histopathology Services Market is 16.9%Q3. Which region holds a major market share for the market?Ans. North America holds a major market share of the Histopathology Services Market in 2022.Q4. Which segment accounted for the largest Histopathology Services Market share?Ans. By end-user, the Diagnostic Laboratories and Reference Laboratories segment accounted for the largest Histopathology Services Market share.Q5. Who are the key players in the Knowledge Process Outsourcing Market?Ans. The global Histopathology Services Market report includes players such as Sonic Healthcare Limited; Laboratory Corporation of America Holdings; Acculabs Diagnostics UK Ltd; TPL Path Labs; UNILABS; Cureline Global Translational CRO; Targos; Cellular Pathology Services; Experimental Pathology Laboratories Inc (EPL); and CHARLES RIVER LABORATORIES, INC.. among others.Q6. What are the factors driving the Histopathology Services Market growth?Ans. The growth of the market can be because of prevalence of various diseases, government support for biotechnology and increasing efforts in R&D activities as well as other activities undertaken by the market players operating in the market.Q7. What are the key growth strategies of Histopathology Services Market players?Ans. The key growth strategies of Histopathology Services Market players are product launch and product approval.Q8. Which region will provide more business opportunities for the Histopathology Services Market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Histopathology Services Market during the forecast period.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
- Chapter 1. Histopathology Services Market Overview
- 1.1. Objectives of the Study
- 1.2. Market Definition and Research & Scope
- 1.3. Research Limitations
- 1.4. Research Methodologies
- 1.4.1. Secondary Research
- 1.4.2. Market Size Estimation Technique
- 1.4.3. Forecasting
- 1.4.4. Primary Research and Data Validation
- Chapter 2. Executive Summary
- 2.1. Summary
- 2.2. Key Highlights of the Market
- Chapter 3. Premium Insights on the Market
- 3.1. Market Attractiveness Analysis, By Region
- 3.2. Market Attractiveness Analysis, By Type
- 3.3. Market Attractiveness Analysis, By End-user
- Chapter 4. Histopathology Services Market Outlook
- 4.1. Histopathology Services Market Segmentation
- 4.2. Market Dynamics
- 4.2.1. Market Drivers
- 4.2.1.1. Driver 1
- 4.2.1.2. Driver 2
- 4.2.1.3. Driver 3
- 4.2.2. Market Restraints
- 4.2.2.1. Restraint 1
- 4.2.2.2. Restraint 2
- 4.2.3. Market Opportunities
- 4.2.3.1. Opportunity 1
- 4.2.3.2. Opportunity 2
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Threat of New Entrants
- 4.3.2. Threat of Substitutes
- 4.3.3. Bargaining Power of Buyers
- 4.3.4. Bargaining Power of Supplier
- 4.3.5. Competitive Rivalry
- 4.4. PESTLE Analysis
- 4.5. Value Chain Analysis
- 4.5.1. Raw Industry Vertical Suppliers
- 4.5.2. Manufacturers
- 4.5.3. Wholesalers and/or Retailers
- 4.6. Impact of COVID-19 on the Histopathology Services Market
- 4.7. Impact of the Russia and Ukraine War on the Histopathology Services Market
- Chapter 5. Histopathology Services Market By Type
- 5.1. Market Overview
- 5.2. Surgical Specimen
- 5.2.1. Key Market Trends & Opportunity Analysis
- 5.2.2. Market Size and Forecast, By Region, 2022-2032 ($Million)
- 5.3. Breast Biopsy
- 5.3.1. Key Market Trends & Opportunity Analysis
- 5.3.2. Market Size and Forecast, By Region, 2022-2032 ($Million)
- 5.4. Lung Biopsy
- 5.4.1. Key Market Trends & Opportunity Analysis
- 5.4.2. Market Size and Forecast, By Region, 2022-2032 ($Million)
- 5.5. Renal Biopsy
- 5.5.1. Key Market Trends & Opportunity Analysis
- 5.5.2. Market Size and Forecast, By Region, 2022-2032 ($Million)
- 5.6. Gastrointestinal Biopsy
- 5.6.1. Key Market Trends & Opportunity Analysis
- 5.6.2. Market Size and Forecast, By Region, 2022-2032 ($Million)
- 5.7. Pancreatic Biopsy
- 5.7.1. Key Market Trends & Opportunity Analysis
- 5.7.2. Market Size and Forecast, By Region, 2022-2032 ($Million)
- 5.8. Skin Tissue Biopsy
- 5.8.1. Key Market Trends & Opportunity Analysis
- 5.8.2. Market Size and Forecast, By Region, 2022-2032 ($Million)
- 5.9. Testicular Biopsy
- 5.9.1. Key Market Trends & Opportunity Analysis
- 5.9.2. Market Size and Forecast, By Region, 2022-2032 ($Million)
- 5.10. Others
- 5.10.1. Key Market Trends & Opportunity Analysis
- 5.10.2. Market Size and Forecast, By Region, 2022-2032 ($Million)
- Chapter 6. Histopathology Services Market By End-user
- 6.1. Market Overview
- 6.2. Diagnostic Laboratories and Reference Laboratories
- 6.2.1. Key Market Trends & Opportunity Analysis
- 6.2.2. Market Size and Forecast, By Region, 2022-2032 ($Million)
- 6.3. Research Institutes
- 6.3.1. Key Market Trends & Opportunity Analysis
- 6.3.2. Market Size and Forecast, By Region, 2022-2032 ($Million)
- 6.4. Others
- 6.4.1. Key Market Trends & Opportunity Analysis
- 6.4.2. Market Size and Forecast, By Region, 2022-2032 ($Million)
- Chapter 7. Histopathology Services Market , By Region
- 7.1. Overview
- 7.2. North America
- 7.2.1. Key Market Trends And Opportunities
- 7.2.2. North America Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.2.3. North America Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.2.4. North America Histopathology Services Market Size And Forecast by Country, 2022-2032, ($Million)
- 7.2.5. The U.S.
- 7.2.5.1. The U.S. Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.2.5.2. U.S. Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.2.6. Canada
- 7.2.6.1. Canada Histopathology Services Market Size And Forecast By Type , 2022-2032, ($Million)
- 7.2.6.2. Canada Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.2.7. Mexico
- 7.2.7.1. Mexico Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.2.7.2. Mexico Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.3. Europe
- 7.3.1. Key Market Trends And Opportunities
- 7.3.2. Europe Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.3.3. Europe Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.3.4. Europe Histopathology Services Market Size And Forecast by Country, 2022-2032, ($Million)
- 7.3.4.1. Germany
- 7.3.4.2. Germany Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.3.4.3. Germany Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.3.5. France
- 7.3.5.1. France Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.3.5.2. France Histopathology Services Market Size And Forecast by Distribution Channel, 2022-2032, ($Million)
- 7.3.6. U.K
- 7.3.6.1. U.K. Histopathology Services Market Size And Forecast By Type , 2022-2032, ($Million)
- 7.3.6.2. U.K. Histopathology Services Market Size And Forecast by End-user, 2022-2032, ($Million)
- 7.3.7. Spain
- 7.3.7.1. Spain Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.3.7.2. Spain Histopathology Services Market Size And Forecast by End-user, 2022-2032, ($Million)
- 7.3.8. Italy
- 7.3.8.1. Italy Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.3.8.2. Italy Histopathology Services Market Size And Forecast by End-user, 2022-2032, ($Million)
- 7.3.9. Russia
- 7.3.9.1. Russia Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.3.9.2. Russia Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.3.10. Rest of Europe
- 7.3.10.1. Rest of Europe Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.3.10.2. Rest of Europe Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends And Opportunities
- 7.4.2. Asia-Pacific Histopathology Services Market Size And Forecast by Country, 2022-2032, ($Million)
- 7.4.3. Asia-Pacific Histopathology Services Market Size And Forecast by Material Type, 2022-2032, ($Million)
- 7.4.4. Asia-Pacific Histopathology Services Market Size And Forecast by Distribution Channel, 2022-2032, ($Million)
- 7.4.5. China
- 7.4.5.1. China Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.4.5.2. China Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.4.6. India
- 7.4.6.1. India Histopathology Services Market Size And Forecast By Type , 2022-2032, ($Million)
- 7.4.6.2. India Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.4.7. Japan
- 7.4.7.1. Japan Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.4.7.2. Japan Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.4.8. South Korea
- 7.4.8.1. South Korea Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.4.8.2. South Korea Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.4.9. Rest of APAC
- 7.4.9.1. Rest of APAC Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.4.9.2. Rest of APAC Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.5. Rest of The World
- 7.5.1. Key Market Trends And Opportunities
- 7.5.2. Rest of The World Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.5.3. Rest of The World Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.5.4. Rest of The World Histopathology Services Market Size And Forecast by Country, 2022-2032, ($Million)
- 7.5.5. Latin America
- 7.5.5.1. Latin America Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.5.5.2. Latin America Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.5.6. Middle East
- 7.5.6.1. Middle East Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.5.6.2. Middle East Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- 7.5.7. Africa
- 7.5.7.1. Africa Histopathology Services Market Size And Forecast By Type, 2022-2032, ($Million)
- 7.5.7.2. Africa Histopathology Services Market Size And Forecast By End-user, 2022-2032, ($Million)
- Chapter 8. Competitive Landscape
- 8.1. Market Overview
- 8.2. Market Share Analysis/Key Player Positioning
- 8.3. Vendor Benchmarking
- 8.4. Developmental Strategy Benchmarking
- 8.4.1. New Product Development
- 8.4.2. Product Launches
- 8.4.3. Business Expansions
- 8.4.4. Partnerships, Joint Ventures, and Collaborations
- 8.4.5. Mergers and Acquisitions
- Chapter 9. Company Profiles
- 9.1. Sonic Healthcare Limited
- 9.1.1. Company Snapshot
- 9.1.2. Financial Performance
- 9.1.3. Product Offerings
- 9.1.4. Key Strategic Initiatives
- 9.1.5. SWOT Analysis
- 9.2. Laboratory Corporation of America Holdings
- 9.2.1. Company Snapshot
- 9.2.2. Financial Performance
- 9.2.3. Product Offerings
- 9.2.4. Key Strategic Initiatives
- 9.2.5. SWOT Analysis
- 9.3. Acculabs Diagnostics UK Ltd
- 9.3.1. Company Snapshot
- 9.3.2. Financial Performance
- 9.3.3. Product Offerings
- 9.3.4. Key Strategic Initiatives
- 9.3.5. SWOT Analysis
- 9.4. TPL Path Labs
- 9.4.1. Company Snapshot
- 9.4.2. Financial Performance
- 9.4.3. Product Offerings
- 9.4.4. Key Strategic Initiatives
- 9.4.5. SWOT Analysis
- 9.5. UNILABS
- 9.5.1. Company Snapshot
- 9.5.2. Financial Performance
- 9.5.3. Product Offerings
- 9.5.4. Key Strategic Initiatives
- 9.5.5. SWOT Analysis
- 9.6. Cureline Global Translational CRO
- 9.6.1. Company Snapshot
- 9.6.2. Financial Performance
- 9.6.3. Product Offerings
- 9.6.4. Key Strategic Initiatives
- 9.6.5. SWOT Analysis
- 9.7. Targos
- 9.7.1. Company Snapshot
- 9.7.2. Financial Performance
- 9.7.3. Product Offerings
- 9.7.4. Key Strategic Initiatives
- 9.7.5. SWOT Analysis
- 9.8. Cellular Pathology Services
- 9.8.1. Company Snapshot
- 9.8.2. Financial Performance
- 9.8.3. Product Offerings
- 9.8.4. Key Strategic Initiatives
- 9.8.5. SWOT Analysis
- 9.9. Experimental Pathology Laboratories Inc (EPL)
- 9.9.1. Company Snapshot
- 9.9.2. Financial Performance
- 9.9.3. Product Offerings
- 9.9.4. Key Strategic Initiatives
- 9.9.5. SWOT Analysis
- 9.10. CHARLES RIVER LABORATORIES, INC.
- 9.10.1. Company Snapshot
- 9.10.2. Financial Performance
- 9.10.3. Product Offerings
- 9.10.4. Key Strategic Initiatives
- 9.10.5. SWOT Analysis
- *The list of company is subject to change during the final compilation of the report
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook